{"entity":{"type":"insider","cik":"0001856587","url":"/insider/0001856587","json_url":"/insider/0001856587.json","name":"Ambrose Kristen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":13,"first":"2022-04-27","last":"2026-03-02","span_basis":"filed_date"},"name_variants":[{"name":"Ambrose Kristen","source":"filing","n_filings":13,"first_seen":"2022-04-27","last_seen":"2026-03-02"}],"transactions":[{"id":5954743,"accession":"0000875320-26-000125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000125","line_url":"/filing/0000875320-26-000125#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001856587","owner_name":"Ambrose Kristen","owner_display_name":"Ambrose Kristen","owner_url":"/insider/0001856587","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":357.0,"shares_display":"357","price_per_share":483.36,"price_display":"483.36","price_state":"stated","total_value":172559.52,"total_display":"172,559.52","total_whole":"172,560","shares_owned_after":6624.0,"shares_owned_after_display":"6,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-26","filed_date":"2026-03-02","scope":"insider"},{"id":6080135,"accession":"0000875320-26-000104","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-26-000104","line_url":"/filing/0000875320-26-000104#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001856587","owner_name":"Ambrose Kristen","owner_display_name":"Ambrose Kristen","owner_url":"/insider/0001856587","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":223.0,"shares_display":"223","price_per_share":486.35,"price_display":"486.35","price_state":"stated","total_value":108456.05,"total_display":"108,456.05","total_whole":"108,456","shares_owned_after":6981.0,"shares_owned_after_display":"6,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-25","filed_date":"2026-02-26","scope":"insider"},{"id":6051381,"accession":"0000875320-26-000080","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000875320-26-000080","line_url":"/filing/0000875320-26-000080#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001856587","owner_name":"Ambrose Kristen","owner_display_name":"Ambrose Kristen","owner_url":"/insider/0001856587","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":638.0,"shares_display":"638","price_per_share":473.68,"price_display":"473.68","price_state":"stated","total_value":302207.84,"total_display":"302,207.84","total_whole":"302,208","shares_owned_after":7750.0,"shares_owned_after_display":"7,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-19","scope":"insider"},{"id":6051377,"accession":"0000875320-26-000080","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000875320-26-000080","line_url":"/filing/0000875320-26-000080#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001856587","owner_name":"Ambrose Kristen","owner_display_name":"Ambrose Kristen","owner_url":"/insider/0001856587","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1557.0,"shares_display":"1,557","price_per_share":489.46,"price_display":"489.46","price_state":"stated","total_value":762089.22,"total_display":"762,089.22","total_whole":"762,089","shares_owned_after":8388.0,"shares_owned_after_display":"8,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-19","scope":"insider"},{"id":6080117,"accession":"0000875320-26-000036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-26-000036","line_url":"/filing/0000875320-26-000036#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001856587","owner_name":"Ambrose Kristen","owner_display_name":"Ambrose Kristen","owner_url":"/insider/0001856587","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1376.0,"shares_display":"1,376","price_per_share":460.43,"price_display":"460.43","price_state":"stated","total_value":633551.68,"total_display":"633,551.68","total_whole":"633,552","shares_owned_after":10127.0,"shares_owned_after_display":"10,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-11","filed_date":"2026-02-12","scope":"insider"},{"id":5148247,"accession":"0000875320-25-000103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000103","line_url":"/filing/0000875320-25-000103#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001856587","owner_name":"Ambrose Kristen","owner_display_name":"Ambrose Kristen","owner_url":"/insider/0001856587","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":884.0,"shares_display":"884","price_per_share":480.95,"price_display":"480.95","price_state":"stated","total_value":425159.8,"total_display":"425,159.80","total_whole":"425,160","shares_owned_after":9086.0,"shares_owned_after_display":"9,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-25","filed_date":"2025-02-26","scope":"insider"},{"id":4294028,"accession":"0000875320-25-000079","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000079","line_url":"/filing/0000875320-25-000079#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001856587","owner_name":"Ambrose Kristen","owner_display_name":"Ambrose Kristen","owner_url":"/insider/0001856587","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":671.0,"shares_display":"671","price_per_share":455.06,"price_display":"455.06","price_state":"stated","total_value":305345.26,"total_display":"305,345.26","total_whole":"305,345","shares_owned_after":10798.0,"shares_owned_after_display":"10,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-19","scope":"insider"},{"id":4368836,"accession":"0000875320-25-000033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000033","line_url":"/filing/0000875320-25-000033#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001856587","owner_name":"Ambrose Kristen","owner_display_name":"Ambrose Kristen","owner_url":"/insider/0001856587","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1376.0,"shares_display":"1,376","price_per_share":459.83,"price_display":"459.83","price_state":"stated","total_value":632726.08,"total_display":"632,726.08","total_whole":"632,726","shares_owned_after":9953.0,"shares_owned_after_display":"9,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-11","filed_date":"2025-02-12","scope":"insider"},{"id":2719270,"accession":"0000875320-24-000113","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000113","line_url":"/filing/0000875320-24-000113#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001856587","owner_name":"Ambrose Kristen","owner_display_name":"Ambrose Kristen","owner_url":"/insider/0001856587","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":240.0,"shares_display":"240","price_per_share":419.0,"price_display":"419.00","price_state":"stated","total_value":100560.0,"total_display":"100,560.00","total_whole":"100,560","shares_owned_after":7500.0,"shares_owned_after_display":"7,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-02","filed_date":"2024-04-03","scope":"insider"},{"id":2670772,"accession":"0000875320-24-000097","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000097","line_url":"/filing/0000875320-24-000097#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001856587","owner_name":"Ambrose Kristen","owner_display_name":"Ambrose Kristen","owner_url":"/insider/0001856587","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":883.0,"shares_display":"883","price_per_share":425.7,"price_display":"425.70","price_state":"stated","total_value":375893.1,"total_display":"375,893.10","total_whole":"375,893","shares_owned_after":7965.0,"shares_owned_after_display":"7,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-27","scope":"insider"},{"id":2299408,"accession":"0000875320-24-000041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000041","line_url":"/filing/0000875320-24-000041#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001856587","owner_name":"Ambrose Kristen","owner_display_name":"Ambrose Kristen","owner_url":"/insider/0001856587","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1374.0,"shares_display":"1,374","price_per_share":420.24,"price_display":"420.24","price_state":"stated","total_value":577409.76,"total_display":"577,409.76","total_whole":"577,410","shares_owned_after":9676.0,"shares_owned_after_display":"9,676","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-13","scope":"insider"},{"id":7870137,"accession":"0001209191-23-033312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-033312","line_url":"/filing/0001209191-23-033312#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001856587","owner_name":"Ambrose Kristen","owner_display_name":"Ambrose Kristen","owner_url":"/insider/0001856587","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":289.0,"shares_display":"289","price_per_share":329.82,"price_display":"329.82","price_state":"stated","total_value":95317.98,"total_display":"95,317.98","total_whole":"95,318","shares_owned_after":6838.0,"shares_owned_after_display":"6,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-30","filed_date":"2023-06-01","scope":"insider"},{"id":8543745,"accession":"0001209191-23-013695","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-013695","line_url":"/filing/0001209191-23-013695","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001856587","owner_name":"Ambrose Kristen","owner_display_name":"Ambrose Kristen","owner_url":"/insider/0001856587","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1207.0,"shares_display":"1,207","price_per_share":287.54962717481357,"price_display":"287.55","price_state":"stated","total_value":347072.4,"total_display":"347,072.40","total_whole":"347,072","shares_owned_after":7528.0,"shares_owned_after_display":"7,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-02-28","scope":"insider","n_lines":3},{"id":6532532,"accession":"0000899243-22-015762","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-015762","line_url":"/filing/0000899243-22-015762","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001856587","owner_name":"Ambrose Kristen","owner_display_name":"Ambrose Kristen","owner_url":"/insider/0001856587","role":"Officer (SVP & Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":327.0,"shares_display":"327","price_per_share":269.5506116207951,"price_display":"269.55","price_state":"stated","total_value":88143.05,"total_display":"88,143.05","total_whole":"88,143","shares_owned_after":3496.0,"shares_owned_after_display":"3,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-25","filed_date":"2022-04-27","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (SVP & Chief Accounting Officer)","n_filings":13,"first_seen":"2022-04-27","last_seen":"2026-03-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001856587","retrieved_at":"2026-08-22T20:24:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}